Description: This session of the 1990 Valuation Actuary Symposium discusses several issues. First, the recoverability of the deferred policy acquisition cost DPAC asset from future revenues. Second, the allocation of mortality, expenses and investment income to the lines of business. Third, treatment of non-deferrable expenses and fourth, unlocking under FAS97 accounting.

Description: Presented at May 1985 Spring Meeting. This session discussed: Relationship of pricing and valuation actuaries in Canada, Financial reporting system as an information source for product development, Interaction of the pricing actuary, valuation actuary, and investment officer in designing interest-sensitive products, Allocation impact on product development of expense, investment income, tax, and capital, Financial reporting information in changing premium rates for nonguaranteed premium products, Maintaining consistency between pricing and financial projection models, Reserve basis and nonforfeiture basis impact on product development, with special reference to lapse-sensitive products.

Description: This session of the 1990 Valuation Actuary Symposium covers several Statutory, GAAP and Tax topics including the interest assumption for GAAP reserve for investment contracts valued under FAS 97. Also covered are the other assumptions for contracts under FAS97. Additional issues covered is the DAC under Alternative Minimum Tax AMT and the Applicable Federal Rate to use for interest for tax reserves.

Description: Presented at October 19895 Annual Meeting. This session is about statutory, GAAP and management reporting for new life insurance and annuity products and nontraditional distribution systems.

Description: Discusses: [1] the effects of Financial Accounting Standard No. 97 [FAS 97] on recoverability and loss-recognition issues, [2] interest-crediting strategy, ways and means of maintaining the planned interest spread, the effects of the various strategies on lapse experience, and the ultimate effect on recoverability of the deferred acquisition costs, and [3] premium-deficiency testing and the modification of interest, mortality, and expense margins to satisfy the question of loss recognition, or lack of the ability to recover the remaining deferred asset. From the 1988 Record of Society of Actuaries, Vol. 14, No. 3.

Description: 1990 Valuation Actuary Symposium Proceedings is a workshop on statutory, GAAP and tax issues for the valuation actuary. Various specific state regulations are discussed.

Description: Presented at May 1985 Spring Meeting. This session discussed: What measures should be used in setting objectives and evaluating performance for companies and product lines, What variations are appropriate for stock and mutual companies and for United States and Canadian companies.